Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0S0FZ
|
||||
Former ID |
DCL000739
|
||||
Drug Name |
Carisbamate
|
||||
Synonyms |
Comfyde; JNJ 10234094; RWJ 333369; YKP 509; Carisbamate (USAN); JNJ-10234094; RWJ-333369; YKP-509; S-2-O-Carbamoyl-1-o-chlorophenyl-ethanol; [(2S)-2-(2-chlorophenyl)-2-hydroxyethyl] carbamate
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Epilepsy; Focal; Seizure disorder [ICD9: 345, 345.4, 345.5, 345.9, 780.3; ICD10:G40, G40.2, P90, R56] | Phase 3 | [536934] | ||
Company |
Johnson & Johnson
|
||||
Structure |
Download2D MOL |
||||
Formula |
C9H10ClNO3
|
||||
Canonical SMILES |
C1=CC=C(C(=C1)C(COC(=O)N)O)Cl
|
||||
InChI |
1S/C9H10ClNO3/c10-7-4-2-1-3-6(7)8(12)5-14-9(11)13/h1-4,8,12H,5H2,(H2,11,13)/t8-/m1/s1
|
||||
InChIKey |
OLBWFRRUHYQABZ-MRVPVSSYSA-N
|
||||
CAS Number |
CAS 194085-75-1
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
SuperDrug ATC ID |
N03AX19
|
||||
Target and Pathway | |||||
Target(s) | Sodium channel | Target Info | Blocker | [536498], [536845], [536934] | |
KEGG Pathway | Dopaminergic synapse | ||||
Reactome | Interaction between L1 and Ankyrins | ||||
References | |||||
Ref 536498 | Emerging drugs for epilepsy. Expert Opin Emerg Drugs. 2007 Sep;12(3):407-22. | ||||
Ref 536845 | Pharmacological management of epilepsy: recent advances and future prospects. Drugs. 2008;68(14):1925-39. | ||||
Ref 536934 | Progress report on new antiepileptic drugs: a summary of the Ninth Eilat Conference (EILAT IX). Epilepsy Res. 2009 Jan;83(1):1-43. Epub 2008 Nov 12. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.